Brain heterogeneity leads to differential innate immune responses and modulates pathogenesis of viral infections

Cytokine and Growth Factor Reviews

Volumn 30, Issue , 2016, Pages 95-101

  Zegenhagen, Loreen ^a,b   Kurhade, Chaitanya ^c   Koniszewski, Nikolaus ^b   Överby, Anna K ^c   Kröger, Andrea ^a,b  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Brain heterogeneity; Central nervous system; Innate immunity; Type I interferon

Indexed keywords

INTERFERON;

AGING; ASTROCYTE; BRAIN INFECTION; BRAIN NERVE CELL; CELLS BY BODY ANATOMY; CENTRAL NERVOUS SYSTEM INFECTION; CYTOKINE PRODUCTION; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MICROGLIA; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; VIRUS INFECTION; VIRUS PATHOGENESIS; ANIMAL; BRAIN; CELL DIFFERENTIATION; IMMUNOLOGY;

AGING; ANIMALS; BRAIN; CELL DIFFERENTIATION; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 84961219001     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2016.03.006     Document Type: Short Survey

References (95)

1. [1] McGavern, D.B., Kang, S.S., Illuminating viral infections in the nervous system. Nat. Rev. Immunol. 11:5 (2011), 318–329, 10.1038/nri2971.
2. [2] Nair, S., Diamond, M.S., Innate immune interactions within the central nervous system modulate pathogenesis of viral infections. Curr. Opin. Immunol. 36 (2015), 47–53, 10.1016/j.coi.2015.06.011 (Figure 1).
3. [3] Aloisi, F., Ria, F., Adorini, L., Regulation of T-cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes. Immunol. Today 21:3 (2000), 141–148, 10.1016/S0167-5699(99) 01512-1.
4. [4] Schwerk, C., Tenenbaum, T., Kim, K.S., Schroten, H., The choroid plexus-a multi-role player during infectious diseases of the CNS. Front Cell Neurosci., 9(March), 2015, 80, 10.3389/fncel.2015.00080.
5. [5] Detje, C.N., Lienenklaus, S., Chhatbar, C., et al. Upon intranasal vesicular stomatitis virus infection, astrocytes in the olfactory bulb are important interferon beta producers that protect from lethal encephalitis. J. Virol. 89:5 (2015), 2731–2738, 10.1128/JVI.02044-14.
6. [6] Detje, C.N., Meyer, T., Schmidt, H., et al. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J. Immunol. 182:4 (2009), 2297–2304, 10.4049/jimmunol.0800596.
7. [7] Delhaye, S., Paul, S., Blakqori, G., et al. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. U. S. A. 103:20 (2006), 7835–7840, 10.1073/pnas.0602460103.
8. [8] Roth-Cross, J.K., Bender, S.J., Weiss, S.R., Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J. Virol. 82:20 (2008), 9829–9838, 10.1128/JVI.01199-08.
9. [9] Li, J., Liu, Y., Zhang, X., Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5. J. Virol. 84:13 (2010), 6472–6482, 10.1128/JVI.00016-10.
10. [10] van den Pol, A.N., Ding, S., Robek, M.D., Long-distance interferon signaling within the brain blocks virus spread. J. Virol. 88:7 (2014), 3695–3704, 10.1128/JVI.03509-13.
11. [11] Kurhade, C., Zegenhagen, L., Weber, E., et al. Type I Interferon response in olfactory bulb, the site of tick-borne flavivirus accumulation, is primarily regulated by IPS-1. J. Neuroinflamm., 13(1), 2016, 22, 10.1186/s12974-016-0487-9.
12. [12] Alammar, L., Gama, L., Clements, J.E., Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection. J Immunol. 186:7 (2011), 4008–4018, 10.4049/jimmunol.1003757.
13. [13] Menachery, V.D., Pasieka, T.J., Leib, Da., Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection. J. Virol. 84:19 (2010), 9685–9694, 10.1128/JVI.00706-10.
14. [14] Fensterl, V., Wetzel, J.L., Ramachandran, S., et al. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 8:5 (2012), 1–13, 10.1371/journal.ppat.1002712.
15. [15] Lancaster, K.Z., Pfeiffer, J.K., Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response. PLoS Pathog., 6(3), 2010, e1000791, 10.1371/journal.ppat.1000791.
16. [16] Barnett, E.M., Cassell, M.D., Perlman, S., Two neurotropic viruses, herpes simplex virus type 1 and mouse hepatitis virus, spread along different neural pathways from the main olfactory bulb. Neuroscience 57:4 (1993), 1007–1025, 10.1016/0306-4522(93)90045-H.
17. [17] Margolis, T.P., Imai, Y., Yang, L., Vallas, V., Krause, P.R., Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. J. Virol. 81:4 (2007), 1872–1878, 10.1128/JVI.02110-06.
18. [18] Wang, T., Town, T., Alexopoulou, L., Anderson, J.F., Fikrig, E., Flavell, R. a., Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:12 (2004), 1366–1373, 10.1038/nm1140.
19. [19] Samuel a, M., Wang, H., Siddharthan, V., Morrey, J.D., Diamond, M.S., Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc. Natl. Acad. Sci. U. S. A. 104:43 (2007), 17140–17145, 10.1073/pnas.0705837104.
20. [20] Dai, J., Wang, P., Bai, F., Town, T., Fikrig, E., Icam-1 participates in the entry of west nile virus into the central nervous system. J. Virol. 82:8 (2008), 4164–4168, 10.1128/JVI.02621-07.
21. [21] Rudd a, P., Cattaneo, R., von Messling, V., Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion. J. Virol. 80:19 (2006), 9361–9370, 10.1128/JVI. 01034-06.
22. [22] Coyne, C.B., Kim, K.S., Bergelson, J.M., Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2. EMBO J. 26:17 (2007), 4016–4028, 10.1038/sj.emboj.7601831.
23. [23] Weber, E., Finsterbusch, K., Lindquist, R., et al. Type I interferon protects mice from fatal neurotropic infection with Langat virus by systemic and local anti-viral response. J. Virol. 88:21 (2014), 12202–12212, 10.1128/JVI.01215-14.
24. [24] Iannacone, M., Moseman, E.A., Tonti, E., et al. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 465:7301 (2010), 1079–1083, 10.1038/nature09118.
25. [25] Nair, S., Michaelsen-Preusse, K., Finsterbusch, K., et al. Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus by specific inhibition of viral replication in neurons. PLoS Pathog., 10(3), 2014, e1003999, 10.1371/journal.ppat.1003999.
26. [26] Kipp, M., Norkute, A., Johann, S., et al. Brain-region-specific astroglial responses in vitro after LPS exposure. J. Mol. Neurosci. 35:2 (2008), 235–243, 10.1007/s12031-008-9057-7.
27. [27] Fredericksen, B.L., Keller, B.C., Fornek, J., Katze, M.G., Gale, M., Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol. 82:2 (2008), 609–616, 10.1128/JVI.01305-07.
28. [28] Kurt-Jones, E.A., Chan, M., Zhou, S., et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U. S. A. 101:5 (2004), 1315–1320, 10.1073/pnas.0308057100.
29. [29] Ishikawa, H., Ma, Z., Barber, G.N., STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461:7265 (2009), 788–792, 10.1038/nature08476 nature08476[pii]\r.
30. [30] Lafaille, F.G., Pessach, I.M., Zhang, S.-Y., et al. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491:7426 (2012), 769–773, 10.1038/nature11583.
31. [31] Farina, C., Krumbholz, M., Giese, T., Hartmann, G., Aloisi, F., Meinl, E., Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 159:1–2 (2005), 12–19, 10.1016/j.jneuroim.2004.09.009.
32. [32] Jack, C.S., Arbour, N., Manusow, J., et al. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175 (2005), 4320–4330, 10.4049/jimmunol.175.7.4320.
33. [33] Ito, T., Amakawa, R., Kaisho, T., et al. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 195:11 (2002), 1507–1512, 10.1084/jem.20020207.
34. [34] Olson, J.K., Miller, S.D., Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173:6 (2004), 3916–3924, 10.4049/jimmunol.173.6.3916.
35. [35] Ousman, S.S., Wang, J., Campbell, I.L., Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J. Virol. 79:12 (2005), 7514–7527, 10.1128/JVI.79.12.7514-7527.2005.
36. [36] Wacher, C., Müller, M., Hofer, M.J., et al. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49 ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J. Virol. 81:2 (2007), 860–871, 10.1128/JVI.01167-06.
37. [37] Cho, H., Shrestha, B., Sen, G.C., Diamond, M.S., A role for Ifit2 in restricting West Nile virus infection in the brain. J. Virol. 87:15 (2013), 8363–8371, 10.1128/JVI.01097-13.
38. [38] Szretter, K.J., Brien, J.D., Thackray, L.B., Virgin, H.W., Cresswell, P., Diamond, M.S., The interferon-inducible gene viperin restricts West Nile virus pathogenesis. J. Virol. 85:22 (2011), 11557–11566, 10.1128/JVI.05519-11.
39. [39] Lucas, T.M., Richner, J.M., Diamond, M.S., The Interferon-stimulated gene Ifi27l2a restricts West Nile virus infection and pathogenesis in a cell-type and region-specific manner. J. Virol.(December), 2015, 10.1128/JVI.02463-15.
40. [40] Schoggins, J.W., Wilson, S.J., Panis, M., et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:7344 (2011), 481–485, 10.1038/nature09907.
41. [41] Robertson, S.J., Lubick, K.J., Freedman, B.A., Carmody, A.B., Best, S.M., Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function. J. Immunol. 192 (2014), 2744–2755, 10.4049/jimmunol.1302110.
42. [42] Best, S.M., Morris, K.L., Shannon, J.G., et al. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J. Virol. 79:20 (2005), 12828–12839, 10.1128/JVI.79.20.12828-12839.2005.
43. [43] Xu, L., Sapolsky, R.M., Giffard, R.G., Differential sensitivity of murine astrocytes and neurons from different brain regions to injury. Exp. Neurol. 169:2 (2001), 416–424, 10.1006/exnr.2001.7678.
44. [44] Geraghty, R.J., Krummenacher, C., Cohen, G.H., Eisenberg, R.J., Spear, P.G., Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280:June (1998), 1618–1620, 10.1126/science.280.5369.1618.
45. [45] Krummenacher, C., Supekar, V.M., Whitbeck, J.C., et al. Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry. EMBO J. 24:23 (2005), 4144–4153, 10.1038/sj.emboj.7600875.
46. [46] Lie, D.-C., Colamarino, S.A., Song, H.-J., et al. Wnt signalling regulates adult hippocampal neurogenesis. Nature 437:7063 (2005), 1370–1375, 10.1038/nature04108.
47. [47] Sharif, A., Renault, F., Beuvon, F., et al. The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain. Neuroscience 126:2 (2004), 263–275, 10.1016/j.neuroscience.2004.02.039.
48. [48] Maragakis, N.J., Rothstein, J.D., Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2:12 (2006), 679–689, 10.1038/ncpneuro0355.
49. [49] Nedergaard, M., Ransom, B., Goldman, S.A., New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 26:10 (2003), 523–530, 10.1016/j.tins.2003.08.008.
50. [50] Fitting, S., Zou, S., Chen, W., Vo, P., Hauser, K.F., Knapp, P.E., Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis. J. Proteome Res. 9:4 (2010), 1795–1804, 10.1021/pr900926n.
51. [51] Matyash, V., Kettenmann, H., Heterogeneity in astrocyte morphology and physiology. Brain Res. Rev. 63:1–2 (2010), 2–10, 10.1016/j.brainresrev.2009.12.001.
52. [52] Ashton, R.S., Conway, A., Pangarkar, C., et al. Astrocytes regulate adult hippocampal neurogenesis through ephrin-B signaling. Nat. Neurosci. 15:10 (2012), 1399–1406, 10.1038/nn.3212.
53. [53] Guillemin, G., Croitoru, J., Le Grand, R.L., Franck-Duchenne, M., Dormont, D., Boussin, F.D., Simian immunodeficiency virus mac251 infection of astrocytes. J. Neurovirol. 6:3 (2000), 173–186 http://www.ncbi.nlm.nih.gov/pubmed/10878708 (accessed 01.28.16).
54. [54] Carbone, K.M., Moench, T.R., Lipkin, W.I., Borna disease virus replicates in astrocytes, Schwann cells and ependymal cells in persistently infected rats: location of viral genomic and messenger RNAs by in situ hybridization. J. Neuropathol. Exp. Neurol. 50:3 (1991), 205–214 http://www.ncbi.nlm.nih.gov/pubmed/2022964 (accessed 01.28.16).
55. [55] Klein, R.S., Williams, K.C., Alvarez-Hernandez, X., et al. Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J. Immunol. 163:3 (1999), 1636–1646 http://www.ncbi.nlm.nih.gov/pubmed/10415069 (accessed 01.28.16).
56. [56] Liu, Y., Liu, H., Kim, B.O., et al. CD4-Independent Infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J. Virol. 78:8 (2004), 4120–4133, 10.1128/JVI.78.8.4120-4133.2004.
57. [57] Reinert, L.S., Harder, L., Holm, C.K., et al. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J. Clin. Invest. 122:4 (2012), 1368–1376, 10.1172/JCI60893.
58. [58] Pfefferkorn, C., Kallfass, C., Lienenklaus, S., et al. Abortively infected astrocytes appear to represent the main source of interferon-β in the virus-infected brain. J. Virol.(December), 2015, 10.1128/JVI.02979-15.
59. [59] Asensio, V.C., Maier, J., Milner, R., et al. Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J. Virol. 75:15 (2001), 7067–7077, 10.1128/JVI.75.15.7067-7077.2001.
60. [60] Amundson, R.H., Goderie, S.K., Kimelberg, H.K., Uptake of [3H]serotonin and [3H]glutamate by primary astrocyte cultures: II. Differences in cultures prepared from different brain regions. Glia 6:1 (1992), 9–18.
61. [61] Morga, E., Faber, C., Heuschling, P., Cultured astrocytes express regional heterogeneity of the immunoreactive phenotype under basal conditions and after gamma-IFN induction. J. Neuroimmunol. 87:1-2 (1998), 179–184 http://www.ncbi.nlm.nih.gov/pubmed/9670860.
62. [62] Won, C.-K., Oh, Y.S., cAMP-induced stellation in primary astrocyte cultures with regional heterogeneity. Brain Res. 887:2 (2000), 250–258, 10.1016/S0006-8993(00) 02922-X.
63. [63] Shrestha, B., Gottlieb, D., Diamond, M.S., Infection and injury of neurons by West Nile encephalitis virus. J. Virol. 77:24 (2003), 13203–13213, 10.1128/jvi.77.24.13203-13213.2003.
64. [64] Binder, G.K., Griffin, D.E., Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 293:5528 (2001), 303–306, 10.1126/science.1059742.
65. [65] Odeberg, J., Wolmer, N., Falci, S., Westgren, M., Seiger, A., Söderberg-Nauclér, C., Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J. Virol. 80:18 (2006), 8929–8939, 10.1128/JVI.00676-06.
66. [66] Wüthrich, C., Dang, X., Westmoreland, S., Fulminant, J.C., et al. virus encephalopathy with productive infection of cortical pyramidal neurons. Ann. Neurol. 65:6 (2009), 742–748, 10.1002/ana.21619.
67. [67] Ohka, S., Sakai, M., Bohnert, S., et al. Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons. J. Virol. 83:10 (2009), 4995–5004, 10.1128/JVI.02225-08.
68. [68] Koike, S., Taya, C., Kurata, T., et al. Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. 88:3 (1991), 951–955, 10.1073/pnas.88.3.951.
69. [69] Cho, H., Proll, S.C., Szretter, K.J., Katze, M.G., Gale, M., Diamond, M.S., Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat. Med. 19:January (2013), 1–8, 10.1038/nm.3108.
70. [70] Olsen, L., Klausen, M., Helboe, L., Nielsen, F.C., Werge, T., MicroRNAs show mutually exclusive expression patterns in the brain of adult male rats. PLoS One, 4(10), 2009, e7225, 10.1371/journal.pone.0007225.
71. [71] Kim, J., Inoue, K., Ishii, J., et al. A microRNA feedback circuit in midbrain dopamine neurons. Science (80-) 317:5842 (2007), 1220–1224, 10.1126/science.1140481.
72. [72] Carson, M.J., Doose, J.M., Melchior, B., Schmid, C.D., Ploix, C.C., CNS immune privilege: Hiding in plain sight. Immunol. Rev. 213:1 (2006), 48–65, 10.1111/j.1600-065X.2006.00441.x.
73. [73] Melchior, B., Puntambekar, S.S., Carson, M.J., Microglia and the control of autoreactive T cell responses. Neurochem. Int. 49:2 (2006), 145–153, 10.1016/j.neuint.2006.04.002.
74. [74] Lawson, L.J., Perry, V.H., Dri, P., Gordon, S., Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:1 (1990), 151–170, 10.1016/0306-4522(90) 90229-W.
75. [75] Kim, W.G., Mohney, R.P., Wilson, B., Jeohn, G.H., Liu, B., Hong, J.S., Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20:16 (2000), 6309–6316 20/16/6309[pii].
76. [76] Cherry, J.D., Olschowka, J.A., O'Banion, M.K., Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J. Neuroinflamm., 11, 2014, 98, 10.1186/1742-2094-11-98.
77. [77] Lai, A.Y., Dhami, K.S., Dibal, C.D., Todd, K.G., Neonatal rat microglia derived from different brain regions have distinct activation responses. Neuron Glia Biol. 7:1 (2011), 5–16, 10.1017/S1740925X12000154.
78. [78] McCluskey, L.P., Lampson, L.A., Local immune regulation in the central nervous system by substance P vs. glutamate. J. Neuroimmunol. 116:2 (2001), 136–146, 10.1016/S0165-5728(01)00295-8.
79. [79] Renno, T., Krakowski, M., Piccirillo, C., Lin, J.Y., Owens, T., TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154 (1995), 944–953.
80. [80] Schnell, L., Fearn, S., Klassen, H., Schwab, M.E., Perry, V.H., Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur. J. Neurosci. 11 (1999), 3648–3658, 10.1046/j.1460-9568.1999.00792.x.
81. [81] Ben-Hur, T., Hadar, J., Shtram, Y., Gilden, D.H., Becker, Y., Neurovirulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression. Arch. Virol. 78:3–4 (1983), 303–308 http://www.ncbi.nlm.nih.gov/pubmed/6318700 (accessed 01.25.16).
82. [82] Ikegami, H., Takeda, M., Doi, K., An age-related change in susceptibility of rat brain to encephalomyocarditis virus infection. Int. J. Exp. Pathol. 78:2 (1997), 101–107 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2694528&tool=pmcentrez&rendertype=abstract (accessed 01.25.16).
83. [83] Schultz, K.L.W., Vernon, P.S., Griffin, D.E., Differentiation of neurons restricts Arbovirus replication and increases expression of the alpha isoform of IRF-7. J. Virol. 89:1 (2015), 48–60, 10.1128/JVI. 02394-14.
84. [84] McKendall, R.R., Woo, W., Possible neural basis for age-dependent resistance to neurologic disease from herpes simplex virus. J. Neurol. Sci. 81:2–3 (1987), 227–237, 10.1016/0022-510X(87) 90098-0.
85. [85] Taguchi, F., Aiuchi, M., Fujiwara, K., Age-dependent response of mice to a mouse hepatitis virus, MHV-S. Jpn. J. Exp. Med. 47:2 (1977), 109–115 http://www.ncbi.nlm.nih.gov/pubmed/194073 (accessed 01.25.16).
86. [86] Derrien, M., Fields, B.N., Reovirus type 3 clone 9 increases interleukin-1a level in the brain of neonatal, but not adult mice. Virology 257 (1999), 35–44.
87. [87] Tardieu, M., Powers, M.L., Weiner, H.L., Age dependent susceptibility to Reovirus type 3 encephalitis: role of viral and host factors. Ann. Neurol. 13:6 (1983), 602–607, 10.1002/ana.410130604.
88. [88] Süss, J., Kahl, O., Aspöck, H., et al. Tick-borne encephalitis in the age of general mobility. Wien Med. Wochenschr. 160:3–4 (2010), 94–100, 10.1007/s10354-010-0756-7.
89. [89] Labrada, L., Liang, X.H., Zheng, W., Johnston, C., Levine, B., Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. J. Virol. 76:22 (2002), 11688–11703, 10.1128/JVI.76.22.11688-11703.2002.
90. [90] Castorena, K.M., Peltier, D.C., Peng, W., Miller, D.J., Maturation-dependent responses of human neuronal cells to western equine encephalitis virus infection and type I interferons. Virology 372:1 (2008), 208–220, 10.1016/j.virol.2007.10.025.
91. [91] Farmer, J.R., Altschaefl, K.M., O'shea, K.S., Miller, D.J., Activation of the type I interferon pathway is enhanced in response to human neuronal differentiation. PLoS One, 8(3), 2013, e58813, 10.1371/journal.pone.0058813.
92. [92] Huh, G.Y., Roh, M.S., Bae, H.R., Age-related regional difference of interleukin-1 expression in rat brain after lipopolysaccharide treatment. J. Korean Med. Sci. 16:1 (2001), 103–107 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11289386.
93. [93] Baruch, K., Deczkowska, A., David, E., et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 346:6205 (2014), 89–93, 10.1126/science.1252945.
94. [94] Kawarabayashi, T., Younkin, L.H., Saido, T.C., Shoji, M., Ashe, K.H., Younkin, S.G., Age-dependent changes in brain, csf, and plasma amyloid {beta} protein in the tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21:2 (2001), 372–381 http://www.jneurosci.org/content/21/2/372 short (accessed 01.26.16).
95. [95] Das, S., Potter, H., Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14:2 (1995), 447–456, 10.1016/0896-6273(95) 90300-3.